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Cervical cancerBackground and purpose: Gynaecological brachytherapy can cause anxiety, distress and discomfort. It is
not known how variation in delivery impacts women’s experiences. To inform future research an online
survey was carried out to identify variations in brachytherapy and support available to women receiving
treatment for locally advanced cervical cancer (LACC).
Materials and methods: An online survey was sent to 44 UK brachytherapy centres using the Qualtrics
survey platform. It included questions about brachytherapy scheduling, inpatient/day case treatment,
anaesthetic/analgesia, non-pharmacological support and health professionals’ opinions regarding holistic
care. A mixture of closed questions with pre-specified options and open questions were employed.
Descriptive statistics were generated to identify variance in UK practice. Free text responses were anal-
ysed using inductive content analysis.
Results: Responses were received from 39/43 eligible centres (91% response rate). Brachytherapy was
predominantly given on an inpatient basis at 65% and day case at 35% of centres. Eleven scheduling
regimes were reported with typical duration of brachytherapy ranging from three to 52 h. The main cat-
egories identified in response to what worked well were: ‘consistency of staff’; ‘good information provi-
sion’ and ‘experienced/skilled/senior staff’. The main categories identified as needing improvement were:
‘training of different staff groups’ and ‘follow up and support’ with many suggestions for service improve-
ments.
Conclusion: The survey provided a comprehensive overview of brachytherapy services for LACC demon-
strating wide variability in scheduling regimes, duration of treatment and holistic care. The findings sup-
port the need to explore women’s experiences with a range of treatment regimes and anaesthesia and
analgesia techniques to inform improvements to future clinical care.
 2021 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 159 (2021) 60–66 This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A systematic literature review has shown that brachytherapy
for gynaecological cancer causes patients varying levels of pain,
anxiety and distress and that there is a need for better pain man-
agement, patient information and support and the development
of non-pharmacological interventions to improve experiences [1].
To date, previous research has not explored non-pharmacological
support services (such as psychological support or use of comple-
mentary therapies) or the impact of treatment schedules on
women’s experiences of brachytherapy. To inform future research
in this area it is first necessary to acquire knowledge of the ways
that brachytherapy is currently provided and the range of existing
support offered to women to help them cope with pain, anxietyand distress due to brachytherapy. The aim of this study was to
identify current UK service provision for women having
brachytherapy for locally advanced cervical cancer.
The objectives were to find out current brachytherapy treat-
ment scheduling, and anaesthesia and analgesia provision for
women receiving treatment for locally advanced cervix cancer to
inform the development of an interview schedule; and to identify
non-pharmacological support currently offered to women before,
during and after brachytherapy.Materials and methods
A cross-sectional survey was developed to gather information
from UK centres carrying out gynaecological brachytherapy for
locally advanced cervical cancer. Survey questions were informed
by research literature [1–4] and discussion with the study team,
Table 1
Type of brachytherapy and inpatient or day case service.




Intracavitary + interstitial 4 (10%)
Intracavitary + hybrid 4 (10%)
Intracavitary + interstitial + hybrid 12 (31%)
Predominant inpatient or day case (n = 37)
Inpatient 24 (62%)
Day case 13 (33%)
P. Humphrey, E. Dures, P. Hoskin et al. Radiotherapy and Oncology 159 (2021) 60–66a brachytherapy anaesthetist, a clinical oncologist and two patient
research partners.
The survey was piloted by four brachytherapy radiographers
resulting in rewording of some questions, to minimise misinterpre-
tation and improve consistency of responses. The final survey con-
sisted of 30 questions covering brachytherapy techniques and
scheduling, anaesthetic/analgesia protocols, inpatient/day case
treatment and non-pharmacological support such as psychologist
input. The survey is provided in supplementary data.
Ethical approval was given by the University Health and
Applied Sciences Faculty Research Ethics Committee (UWE REC
REF No: HAS.18.08.008).
The survey was distributed via the Qualtrics survey platform
to the 44 UK centres reported to be carrying out brachytherapy
for locally advanced cervical cancer listed on the national cancer
statistics database. Responses were requested from the lead
brachytherapy radiographer as the person most likely to have an
overview of the whole brachytherapy service. For three depart-
ments there was no lead radiographer identifiable. Email contact
was made with these departments and an oncologist or physicist
was invited to complete the survey with assistance from nurse or
radiographer colleagues.
The on-line survey invitation was emailed out and responses
collected over a three-month period from November 2018 to Jan-
uary 2019. For non-respondents a reminder was sent out after
one month. The data obtained did not contain personal demo-
graphic information although professional opinions were
requested. All identifiable features were removed from the data
by the doctoral research fellow (PH) prior to sharing with the
research team.
Descriptive statistics were used to analyse data from closed
questions. Respondents free text comments to closed questions
were grouped and summarised. The data from the three open-
ended questions were analysed using content analysis. As survey
data is uni-directional, without opportunities for co-creation
between participant and the researcher, it can be used to provide
‘‘quasi- qualitative” data. The analytical process was informed by
methods described by Kondracki et al [5], Hsieh and Shannon [6],
and Elo and Kyngäs [7] using an inductive or ‘‘grounded” approach,
with codes and categories arising from the data rather than apply-
ing a theory or preconceived ideas to the data. Frequency of codes
was used to provide a sense of the significance of the results. The
data were initially examined by PH by reading and rereading, to
‘‘achieve immersion and obtain a sense of the whole” [6]. Analysis
began with open coding of responses. NVivo software was used to
provide a rigorous approach for counting code frequency. Codes
that shared a similar meaning were grouped into categories.Results
One of the 44 UK centres invited to take part in the survey was
not eligible as their brachytherapy services had recently been
transferred. Of the 43 remaining centres, 39 responses were
received (91% response rate); including two from Scotland, one
from Northern Ireland and 36 in England. The centre in Wales
did not respond.
Most centres reported using high dose rate brachytherapy
(36/39, 92%) and only four centres using pulsed dose rate (10%),
with one using both HDR and PDR. Table 1 shows responses for
type of brachytherapy, intracavitary, interstitial or hybrid (combi-
nation of intracavitary and interstitial in the same procedure), and
predominant inpatient or day case service.
Eight respondents selected more than one fractionation regime
from the nine options provided. Four responses were removed
from the data as they did not correlate with responses to other61questions, therefore likely to be errors of option selection. Fig. 1
shows the fractionation regimes selected by the respondents with
‘‘other” regimes described as ‘‘3 fractions (one insertion) over
3 days” and ‘‘3 fractions over 2–3 weeks”.
The average duration that applicators were in place for a typical
insertion, measured from the start of the applicator insertion to
applicator removal, ranged from 3 to 52 h with a median of 16 h.
Interrogation of the data, including free text comments, showed
the number of insertions predominantly used at each centre
(Table 2).
The data indicates that there are 17 centres using long duration
regimes involving overnight stays with applicators in place, and 17
centres using shorter duration regimes.
Respondents’ comments showed that duration was influenced
by factors such as scheduling choice, which is dependent on com-
plexity of treatment (may choose multiple fractions for one inser-
tion for a very complex case) and patient factors such as co-
morbidities or contraindications (may choose shorter regime).
Respondents provided examples of ways in which duration was
shortened including using a Smit sleeve (indwelling intrauterine
tube) for subsequent treatments; copy plans; and imaging/re-
planning not used before subsequent fractions. Seven respondents
commented on delays caused by increased planning time due to
increased complexity; new addition of MRI imaging/planning;
addition of interstitial needles; doctors in training requiring longer
for planning (contouring) and limited access to MRI scanner. Other
examples of causes of delays were limited clinician availability for
applicator removal, medical complications needing clinician input;
variable time needed in recovery room after general anaesthetic
and number of cases that day, that is, more cases increases
duration.
General anaesthetic (GA) was the most reported type of anaes-
thesia, by 82% (n = 31/38). Fig. 2 shows the responses for types of
anaesthesia routinely used.
Eighteen respondents added free text comments on anaesthe-
sia. Most comments referred to patient suitability, contraindica-
tions or medical reasons for anaesthesia selection. Four
respondents mentioned patient choice or preference, for example:
‘‘Patients are given a choice of GA or spinal. Most prefer a GA but
occasionally we have a patient who would prefer a spinal”
One respondent indicated a different anaesthetic regime for ini-
tial and subsequent insertions:
‘‘We only use general anaesthetic for the first fraction. Lorazepam is
given 1 hour before subsequent fractions”.
Most respondents indicated the use of four or five analgesia
options. Fig. 2 shows type of analgesia used and number of respon-
dents selecting each option.
The use of additional analgesia for applicator removal was
reported by 68% of respondents (n = 26/38). Details of additional
analgesia for applicator removal was provided in a free text com-
ments box by 25 respondents (Fig. 2).
Fig. 1. Fractionation regimes routinely used (n = 34).
Brachytherapy for locally advanced cervical cancer: A survey of UK provision of care and supportRespondents indicated that in most centres information/sup-
port was provided by radiographers before and during brachyther-
apy and by radiographers or specialist nurses after brachytherapy.
In addition to the pre-defined categories, in free text comments
some respondents reported that additional support was available
from clinical psychology and counselling when required instead
of routinely, and some patients had access to support facilities at
on-site charitable organisations. Fig. 3 shows the type of support
routinely provided before, during and after brachytherapy.
Participants were asked to rate how well they thought women
were supported before, during and after brachytherapy in their
department. Fig. 4 shows the 38 responses.
For the questions relating to what works well, what needs to be
improved and adaptations for patients with special needs these
data for each question were open-coded and grouped into cate-
gories and the number of responses in each category was counted.
For each question an example from each category is shown in
Table 3. Data from further comments at the end of the survey were
managed in the same way and examples presented in Table 3.Discussion
Survey responses indicated wide variation in insertion regimes
with 17 respondents reporting a predominant use of a one or two
applicator insertion regime which involved overnight stays with
applicators in place, and 17 reporting three or four insertion
regimes of shorter durations. This variation in regime choice has
led to the large range of typical duration of applicators in place,
from three to 52 h. The free text comments indicated that this wide
disparity had arisen for complex operational reasons, such as
access to operating theatres, availability of ward beds, numbers
of oncologists and physicists and access to imaging facilities such
as MRI. There was no evidence of patient input into individual
treatment plans or service design, although this was not explicitly
asked in the survey. Brachytherapy for cervical cancer causes
patients varying levels of pain, anxiety and distress, and it has been
proposed that the duration of the procedure and repetition of the
procedure will impact on women’s experiences [1]. Interstitial or
hybrid techniques and use of MRI planning has been recommended
and widely implemented, with the aim of improving local tumourTable 2
Typical number of applicator insertions (n = 34).
Typical number of applicator insertions 1 2 3 4
Number of respondents (n = 34) 10 7 14 3
62control [2,4,8–12]. However, decisions on how to implement this
development have been left to individual centres, as they have
many different logistical factors to consider. Although service users
cannot comment on lived experiences of different regimes, it
would be useful to obtain their feedback on the brachytherapy
insertion regime that they experienced so their views can be taken
into consideration when deciding future fractionation regimes.
It is widely recognised that interstitial brachytherapy is likely to
cause patients more pain than intracavitary brachytherapy
[10,13,14]. Two studies which reported anaesthesia/analgesia
regimes with long durations of interstitial brachytherapy had good
outcomes using Patient Controlled Analgesia (PCA) after a general
anesthetic [15] or a combined epidural medication [13]. In this sur-
vey six respondents reported no use of PCAs or epidural with long
duration regimes. Further research is needed to assess women’s
experiences of pain with or without the use of continuous pain
management (PCA or epidural) and for long duration procedures
with interstitial needles.
Applicator removal has been reported to be the most problem-
atic part of brachytherapy. One study reported that instrument
removal was ‘‘the most physically uncomfortable aspect” and
another that ‘‘maximal levels of pain coincided with applicator
manipulation during insertion and removal” [16,17]. Smith et al.
[18] reported a sudden increase in pain during applicator removal,
at a time when other analgesia had worn off. They concluded that
inhalation of nitrous oxide gas was appropriate to minimise this
short term discomfort as it is short acting, easy to administer and
has a rapid effect due to absorption into the blood stream through
lung alveoli. A retrospective five year analysis in a single centre
recommended that regional anaesthesia should continue until
the end of the brachytherapy, including applicator removal [19].
In the current survey almost a third of respondents reported no
additional analgesia being routinely offered at applicator removal.
Where it was offered, the most popular additional drug at applica-
tor removal was nitrous oxide and oxygen gas (Entonox/gas and
air). For some respondents the use of continuous pain management
with PCA or epidural or spinal anaesthetic for short procedures
may be considered sufficient for applicator removal. However,
there were four centres that did not use continuous pain manage-
ment techniques and did not routinely offer any additional analge-
sia at applicator removal. This was corroborated with some free
text comments about analgesia needing to be improved. Therefore,
inadequate pain management, especially for applicator removal is
likely to still be a problem for some patients.
Some respondents indicated little experience of patients with
special needs such as learning disabilities, dementia, victims of
sexual abuse or female genital mutilation. This may reflect the
Fig. 2. Type of anaesthesia; Type of analgesia; Additional analgesia for applicator
removal. Abbreviations: IV = Intravenous; IM = Intramuscular; PCA = Patient
controlled analgesia; NSAIDS = Non-steroidal anti-inflammatory drugs.
Fig. 3. Support routinely provided before, during and after brachytherapy (n = 38).
Fig. 4. How well do you think women are supported before, during and after
brachytherapy in your department? (n = 38).
P. Humphrey, E. Dures, P. Hoskin et al. Radiotherapy and Oncology 159 (2021) 60–66low numbers of women having this type of brachytherapy, espe-
cially in smaller centres. However, it is important to consider that
in the UK the incidence of women who experience domestic vio-
lence during their lifetime is one in four, and one in five for sexual
assault [20]. Therefore, it may be assumed that clinicians will
sometimes be unaware of patients’ histories and access to addi-
tional support for brachytherapy would not have been sought.
However, it is encouraging to see that many respondents in this
survey reported that they have access to specialist support services
and would assess and adapt their provision according to individual
patient needs, assuming that those with special needs are
identified.
Respondents rated highly the support given to patients at their
centre before, during and after brachytherapy. In relation to what
worked well, respondents referred to continuity of care,
experienced staff, building trust and rapport and dedicated staff.63However, some responses regarding what needed to be improved
identified care on the wards and education of ward and other staff.
In a previous interview study, many women commented on their
‘‘Supportive treatment team (specialized staff members
brachytherapy)” [21]. This contrasts with a report of the lived
experiences of receiving LDR or PDR brachytherapy, where women
reported some negative aspects of care, mostly relating to nursing
care on the wards. Some women were distressed by nurses ‘‘lack of
understanding of the technology associated with the treatment”
and an uncaring attitude or awareness of the ordeal that they were
going through. Participants reported inconsistent care in pain man-
agement, and a lack of help with basic hygiene and empathy and
understanding [22]. Overall, the literature suggests mixed experi-
ences that may be dependent on the level of knowledge, skill and
experience of individual members of the brachytherapy or ward
nursing teams and the supportive relationship they develop with
patients. This is similar to contrasting and sometimes contradic-
tory findings in this survey, that staff views on provision of support
are highly positive but some state that provision of care and staff
education needs improvement. Further research is therefore war-
ranted to explore patients’ views of care and support at each stage
of treatment.
Survey respondents commented on the good provision of infor-
mation and frequent opportunities for patients to ask questions.
Table 3
Free text answers and comments.
SURVEY Question Category Example of response n*
WHAT WORKS WELL IN YOUR
DEPARTMENT?
NUMBER OF RESPONSES TO
QUESTION = 33
(85% OF TOTAL SAMPLE)
Consistency of staff . . .knowing the same radiographer from the start of EBRT to brachy support on day. 19
Good information from staff I feel that we give a lot of information at different times during the EBRT pathway so that




We have a very focussed female oncologist, 2x CNS and specialist gynae surgical ward nurses plus
brachytherapy/review radiographer.
13





MDT team looking for ways to improve patient experience and service developments to reduce
pathway length on the day for patients.
6
Relationships of trust,
rapport and empathy from
staff
They are treated by a small team, all who have met the patient before, so there is already a
relationship and a rapport with the patient.
5
Good follow up/aftercare We do radiographer led calls and follow ups at 3 and 6 weeks for support and to offer advice re
dilators. Patients find it helpful to know they can contact us at any time. . .
4
Provision of good facilities We have our own theatre which is on the day unit where the patients are cared for and this is a
great bonus.
4
Patient care on wards . . .dedicated HDR sisters provide one to one care during inpatient stay. 4
Good teamwork Good relationships and communication between all staff members involved in patient care. 2
Access to psychological
support
. . .ongoing support during treatment and referrals for Psych Onc where appropriate. 1
WHAT NEEDS TO BE IMPROVED IN
YOUR DEPARTMENT?
NUMBER OF RESPONSES TO
QUESTION = 32
(82% OF TOTAL SAMPLE)
Training for different staff
group
Support for radiographers, ongoing training etc to deal with the emotional side of the treatment
experience.
12
Follow up and support after
brachytherapy
Patients have a 10 day telephone F/U following completion of Brachy. They have a 3 month F/U in
Gynae. I don’t feel this is adequate for some women.
10
Pharmacological management It is being discussed whether to provide GA patients with a spinal block to aid with the control of
the discomfort.
6
Appropriate allocation of staff We have no dedicated brachy radiographer- very physics and technician led. . . 6
The patient pathway Access to the MRI facilities at the times required improved to save the waiting time 6
Obtain and use patient
feedback
Since introducing hybrid technique (interstitial/intracavitary) we have not got patient feedback. 4
Care on wards Improvements in the care and understanding of the procedure on the ward. 3
Ward facilities Although we try and allocate a side room to each patient, it isn’t always possible. 2
Access to complementary
therapies
Need more therapists to provide relaxation while patients on ward. 2
Information and support I would like to ask some of our patients to consider writing a short paragraph about their
experience to show to future patients to alleviate their concerns/provide support before
treatment.
2
Technical developments Patients often report that they are transferred a great deal and the ward is at the opposite end of






VICTIMS OF SEXUAL ABUSE OR
FEMALE GENITAL MUTILATION
NUMBER OF RESPONSES TO
QUESTION = 33
(85% OF TOTAL SAMPLE)










We have involved clinical psychologists early on to prep ahead for particularly anxious patients/
history of sexual abuse.
8
Extra CNS or radiographer
support
Unfortunately that support is limited to CNS and radiographers, we do not have routine
counselling services.
5
Adaptations to treatment Altered fractionation and library plan available for patients unable to tolerate/cope with
inpatient procedure.
5





Information and communication throughout. 3
Staff get to know the patient
over time
. . .we get to know the patient well from first consultation and support them throughout the




We also follow the patients through the dept from theatre to MRI then CT and back to the ward,
so they have a familiar face with them throughout the procedure.
2
Extra time Allow extra time for information and support meetings with the patients. 2
Earlier involvement . . .we would arrange to meet with the patient earlier in their pathway to sensitively address any 2
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Table 3 (continued)
SURVEY Question Category Example of response n*
issues and individualise our approach accordingly.
Consider gender of staff Both male and female staff are available according to the patients . . . requests. 2
Accommodate patient’s
requests
I am not sure we have needed it but will always work with requests from patients. 2
FURTHER COMMENTS
NUMBER OF RESPONSES TO
QUESTION = 13
(33% OF TOTAL SAMPLE)
Follow up support and late
effects
. . .I suspect that this type of treatment could have significant mental effect and that survivorship




The possible option of moving to a 4 fraction technique will have implications- a longer stay or




. . .removal of the applicators using ‘gas + air’ has triggered thoughts about child-birth and has










It is a very labour intensive, time consuming process and relies very much on the co-operation of




One of our consultants is keen to move towards interstitial needles for these patients, which is
something we currently do not offer.
2
*n = the number of open-ended responses in each category.
P. Humphrey, E. Dures, P. Hoskin et al. Radiotherapy and Oncology 159 (2021) 60–66However, Velji and Fitch [22] reported that despite information
provision, women did not feel fully prepared for their experience
of brachytherapy. The effectiveness of information provision in
reducing anxiety and distress is therefore questionable. A study
of LDR brachytherapy reported women’s satisfaction with informa-
tion provision, but some negative views caused by a gap between
theoretical knowledge and the actual experience of brachytherapy
[23]. A study of the informational needs of women having
brachytherapy for locally advanced cervical cancer reported signif-
icant unmet needs, such as information about side-effects, sexual
intercourse, treatment preparation and appointments [24]. Their
findings were used to develop patient-centred guidelines for use
by multidiscplinary teammembers, to integrate patient experience
into the development process [25]. The findings from this survey
support the need to explore women’s experiences of brachyther-
apy and suggestions for improvement in different UK settings. Rec-
ommendations from a recent study to improve well-being for
women receiving vaginal brachytherapy (post hysterectomy) will
be considered for comparison [26].
There are some limitations to this study as questionnaires do
not provide an opportunity for the researcher to clarify ambiguities
or check that questions have been interpreted correctly. It is also
not possible to seek additional information via survey although
the opportunity for respondents to provide free text comments
did add valuable detail.Conclusions
The excellent response rate to the survey provided a compre-
hensive overview of brachytherapy service provision for LACC
which is highly likely to be representative of service provision in
the UK. This survey has demonstrated a wide variability in
scheduling regimes and duration of treatment. Anaesthesia (GA
or spinal) was reported to be used in all centres but analgesia after
applicator insertion and for applicator removal was more variable.
Whilst these factors are highly likely to impact on women’s expe-
riences it is important not to make assumptions but to ask the ser-
vice users directly. The findings therefore support the need to
explore women’s experiences with a range of different treatment
regimes and anaesthesia and analgesia techniques to inform
improvements to future clinical care.65Funding source declaration
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